神威藥業集團有限公司
SHINEWAY PHARMACEUTICAL GROUP LTD.
神威藥業集團是專業從事現代中藥研發、生產、銷售的大型企業，為全國醫藥百強、全國中藥行業十強企業、香港主板市值最大的200家上市公司之一，“神威”商標為中國馳名商標，入選中國500最具價值品牌。神威藥業集團主要針對中老年用藥、兒童用藥、抗病毒用藥三大高速增長的目標市場，專注發展現代中藥新劑型、新產品，形成了以處方藥為主、以現代中藥注射液、中藥軟膠囊、中藥顆粒劑三大劑型為特色的強大優勢產品組合。
Shineway Pharmaceutical Group Ltd., founded since 1992, is a large comprehensive group with modern Chinese medicine as its dominant business. Shineway’s comprehensive competitiveness ranks among top 20 of pharmaceutical industry, taking fourth place in traditional Chinese medicine industry. As the largest traditional Chinese medicine manufacturer by market capitalization in Hong Kong stock exchange, Shineway owns “SHINEWAY” “WUFU” and “SHENMIAO” as three famous trademarks in China.More than ten main varieties of“Wufu” Xinnaoqing soft capsules, Huoxiang Zhengqi soft capsules, Liyan Jiedu granules, Shujin Tongluo granules, synovitis granules and Shuxuening injections produced by the company have registered their products in nearly 20 countries, including Singapore, Vietnam, Indonesia, Thailand, Canada and Australia. The company's main trademark "SHINEWAY" has been registered in Madrid Agreement, more than 30 countries such as the United Kingdom, the United States, South Korea, Indonesia
藿香正氣軟膠囊、六味地黃丸
Abdominal-Eze Soft Capsule、Six Herbs Pill
